Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.40 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.40 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20691937 | 0.81 | P2RY1 (0.36) | P2RY1 | |
| SCHEMBL20691935 | 0.80 | P2RX3 (0.42) | P2RX3 | |
| SCHEMBL20691939 | 0.70 | P2RY1 (0.40) | P2RX3P2RX2P2RY1 | |
| SCHEMBL24321961 | 0.69 | TAS1R3 (0.48) | TAS1R3TAS1R1P2RX3P2RX2P2RY1 | |
| SCHEMBL24680579 | 0.68 | — | — | |
| SCHEMBL20691298 | 0.66 | AHCY (0.37) | P2RY1 | |
| SCHEMBL24059955 | 0.66 | TAS1R3 (0.72) | TAS1R3TAS1R1P2RX3P2RX2P2RY1 | |
| SCHEMBL20673218 | 0.66 | TAS1R3 (0.72) | TAS1R3TAS1R1P2RX3P2RX2P2RY1 | |
| SCHEMBL24444066 | 0.64 | ALDH1A1 (0.42) | P2RX3 | |
| SCHEMBL20673210 | 0.64 | TAS1R3 (0.67) | TAS1R3TAS1R1P2RX3P2RX2P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3752516-B1 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2022-02-23 | — | — | EP | disclosed |